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The HBV genome is a circular partially double-stranded DNA molecule. It contains four overlapping open 
reading frames (ORFs) genes. The S (preSJ, preS2) region(s) encodes the major (small), middle and 
large proteins (HBsAg). The C and pre-C regions encode HBcAg and HBeAg. The X region encodes a 
polypeptide expressed during HBV infection. The P region codes for a protein with several functions in 
replication. Four classes of HBV mRNAs have been identified. In the HBV genome the pre-Sl promoter 
expresses the large protein. The pre-S2/S promoters produce both major and middle proteins. The X 
promoter produces 0.7 and 0.9 kb transcripts. The C and pre~C promoters produce the Core, pol(HBcAg), 
and the HBeAg proteins. Enhancer I and II are key regulatory elements in the transcriptional regulation 
of HB V. The activity of enhancer II is highly the liver specific. Enhancer II activates the transcriptional 
activity of both the pre-Sl and preS2/S promoters. Two HBV enlmncers strongly affect the activity of all 
three major HBV promoters. A box-α in the II-A and box-β in II-B elements of HBV genome, are 
necessary for the enhancer II function. Either box-α or box-β can regulate the activity of the Core promoter, 
a, b, f proteins and c, d proteins bind to box-α and box-β, respectively, and mediate the enhancer function. 
The study of human HBV which is one of the smallest 
known for animal virus, has been severaly limited 
because it only infects humans and because a tissue 
culture system in which this virus can be propagated 
is not available. (HBV can not be propagated in vitro). 
The hepatitis B surface antigen (HBsAg) transcription 
has been studied only in cell lines containing HBV 
DNA integrated into chromosomes, and HBsAg-rela-
ted mRNAs 2.0 to 2.5 kb long have been described 
[1—5 J. 
The hepatitis B viruses, also called Hepadna-
viruses [6], represent a small group of primarily 
hepatotropic enveloped DNA viruses that proceed 
through reverse transcription of a RNA intermediate 
[7, 8 ] in a manner analogous to that of retroviruses. 
Beside the HBV of man [9 ], this family (Hapad-
naviridae) includes woodchuck hepatitis virus (WHV) 
of Marmota топах [10], ground squirrel hepatitis B 
virus (GSHV) of Spermophilus beecheyi [11 ], the tree 
squirrel hepatitis B virus [12], duck hepatitis B virus 
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(DHBV) of Anas domesticus [13] and other ducks, 
heron hepatitis B virus in gray herons [14] and 
probably others. This taxonomy is derived from the 
relative hepatotropism of virus family members, their 
common virion morphology, genome size, structure 
and organization, and common mechanism of genome 
replication. All the viruses exhibit a strict host 
specificity; the human virus replicating only in man 
and a small number of higher apes. 
The disease state induced by infection with HBV 
is manifest in varying ways characterized by the 
extent of liver inflammation and damage arid viral 
persistence. In a small percentage of cases, primary 
infection leads to fulminant hepatitis resulting in 
severe liver dysfunction with very high mortality. 
Primary infection is most often resolved by complete 
clearance ol the virus and development of immune 
memory to counter reinfection, but 5—10 % of 
infected adults develop chronic infection characterized 
by the persistence of viral antigens in the serom and 
accompanied by varying degrees of hepatic injury. 
This disease state may continue after integration of 
HBV DNA into the hepatocyte genome from which 
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transcription of viral antigen genes may continue in 
the absence of virion production. H BV can be detec-
ted in the hepatocyte either as a free DNA molecules 
or in an integrated form [15]. ChiOnically infected 
patients are predisposed to developing hepatocellular 
carcinoma (HCC) [16—19] with more than 100-fold 
greater probability than non-infected individuals 
[20]. The presence of integrated HBV DNA in 
hepatocellular carcinoma has led to the hypothesis 
that viral integration may contribute to the process of 
hepatocarcinogenesis [21, 22]. In hepatocytes that 
have undergone malignant transformation, part of 
HBV DNA are integrated into chromosomes of the 
host [23—31]. 
However, the mechanisms of integration, res-
ponsible for Iumorigenesis and for the shutdown of 
HBV gene expression and replication in hepatocellular 
carcinoma remain unclear [32], but the integrated 
HBV subgenomes are suspected to be carcinogenic [3, 
33—37]. Hepatitis B constitutes a major worldwide 
health problem with the number of chronically in-
fected people currently estimated in excess of 250 
million [38—40]. 
HBV has a partially double stranded, open-
circular genome of 3.2 kb which contains four open 
reading frames (ORFs) including the S-gene encoding 
the suiiace antigen (HBsAg) and the C-gene encoding 
the Core antigen (HBcAg) (Fig. I). A large ORF 
encompassing most of the viral genome encodes the 
viral polymerase while the fourth ORF encodes a 
protein of 154-amino acid residues which has been 
termed the X antigen (HBAg). Because the function 
of this product in the viral life cycle is still under 
intensive investigation. 
Although the viral genome and RNA transcripts 
can be detected in extra-hepatic tissues of HBV-
infected chimpanzees and in transgenic mice carrying 
the HBV DNA [39, 41—43], liver is still the principal 
site of clinical disease in which HBV actively repli-
cates. 
Infected plasma contains viral particles of dif-
ferent sizes and forms. During infection of humans, 
the virus (Dane particle) and the two prominent 
subviral particles (filaments and 22-nm particles) are 
observed in the sera of infected individuals. The 
virion has a diameter of approximately 42 nm (Dane 
particle) with a 27-nm core. The 22 nm diameter 
particles consist of empty viral envelopes that bears 
the hepatitis B surface antigen (HBsAg). Filaments 
and 22 nm particles consist only of the HBsAg and 
cellular lipid. Careful examination of the surface 
antigen [44, 45] has indicated that it is composed of 
at least three pairs of proteins: p24 and gp27; gp33 
and gp36; p39 and gp42 (p: protein, gp: glycoprotein), 
where the second protein in each pair is a gly-
cosylated from of the first. It is apparent from the 
work of a number of investigators [5, 31, 46] that 
these proteins are derived from a large open reading 
frame (one of OR Fs) and originate from the first 
three strongly conserved ATGs in that region. This 
particular ORF consists of an «S» region that is 
preceded by an in-phase reading frame, which has 
been designated as «pre-surface» or «рге-S». The 
pre-S region may be further subdivided into «pre-Sl» 
and «pre-S2» [46—48]. The 42 nm HBV particles 
(Dane particle = virion) contains three different sur-
face proteins which are referred to as «major (small)» 
protein, «middle» protein and «large» protein. (The 
outer envelope of the virion is arrayed by three 
surface S proteins; the major (small) S, the middle S, 
and the large S [17, 44, 49, 50—53)). The large 
surface protein (LS) is translated from the first ATG 
codon of the surface open reading frame, while the 
middle and small (major) forms are translated from 
in-frame ATG codons further downstream. Inside the 
viral envelope, there is the 27-nm «Core» particle 
formed by subunits of core proteins referred to as 
HBcAg. It contains the viral polymerase and the 
partially double stranded DNA molecule to which a 
protein is covalently linked (for a review see [54]). 
All three forms of the surface (envelope) proteins 
(antigens) which are co-linear in the carboxyl-ter-
minal protein, are needed for virion production and 
cotranslationally inserted into the Endoplasmic Reti-
culum (ER) as transmembrane proteins and, together 
with envelope cytoplasmic core (nucleocapsid) par-
ticles, form mature virions that are secreted via the 
constitutive secretory pathway [53], but an over-
production of the large form can result abnormal 
particle formation that becomes inspissated in the ER 
and damages the host cell [55, 56]. In addition, the 
middle and/or small forms, in the absence of other 
viral proteins, can bud into the lumen and be secreted 
in the form of spherical and filamentous subviral 
particles. LS, in contrast cannot be secreted when 
expressed alone but instead is retained within the cell 
in the form of intraluminal particles [55, 57, 58—60, 
102 ]. 
If LS is coexpressed with the other forms of 
surface protein, they form heteromultimers whose 
phenotype depends on the relative amounts of the 
various surface proteins: a small relative amount of LS 
results in secretion, while a large amount results in 
retention. This retention affects the secretion not only 
of noninfectious subviral particles but also of the 
infectious virion particles and, therefore, is delete-
rious to the viral life cycle [61 ]. Not surprisingly, in 
the infected cell, LS is usually synthesized in much 
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Fig. 1. HBV genome organization and viral transcripts (in ayw subtype): Open reading frames are represented by arrows, and Iwxes 
represented transcriptional control regions. The stars correspond to the ATG codons and the position given at the end of the arrows correspond 
to those of the stop codons. Abbreviation: GRE - Glucocorticoid Responsive Element, DRI and DRIT - primary site for replication 
smaller amounts than the middle and small surface 
proteins. This differential regulation is achieved by 
the presence of two independent promoters [62 ]. The 
upstream pre-Sl promoter gives rise to transcripts 
that are translated mainly into LS, while the down-
stream S promoter gives rise to transcripts capable of 
translation into only the middle and small surface 
protein. Since the amount of pre-Sl mRNA is nor-
mally much smaller than the amount of S mRNA, 
there is insufficient LS to prevent secretion. Because 
the relative ratio of LS to the middle and small 
surface proteins synthesized by HBV is crucial to its 
replication, it was found, that there is a feedback 
mechanism to ensure a balanced synthesis of these 
proteins, in that LS significantly activates the S 
promoter [63]. This activation is con-elated whit the 
intracellular retention of LS and is mimicked by 
agents that induce ER stress [63 ], Conversely, LS 
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also activates cellular promoters known to respond to 
ER stress, but not irrelevant promoters. Therefore, 
overexpression of LS and subsequent intracellular 
particle retention appear to activate the S promoter by 
an intracellular signalling pathway induced by ER 
stress. This activation would in turn lead to increased 
synthesis of the middle and small surface proteins 
and, hence, allow secretion of both subviral and virion 
particles [63]. (The pre Sl and S promoters will 
explaind in other part of litis review.) 
The investigation of the HBV life cycle has been 
hampered by the lack of a system for HBV replication 
in vitro. However, in vitro culture systems whit human 
hepatoma cells that are capable of producing HBV 
particles by DNA transfection have been successfully 
established by various groups of investigators [64— 
67, 71]; cloning and sequencing [47, 48], the use of 
animal model systems [7, 68], and eukaryotic exp-
ression system [69, 70], however, have brought some 
insight into the HBV gene organization and life cycle. 
Different systems are now available to study HBV 
gene expression. Virus multiplication and production 
of surface antigens have been obtained in hepatoma 
cell lines transfected by cloned HBV DNA [71 ], in 
adult [72] and fetal [73] primary human hepatocytes 
cultures by direct infection, This has been clone also 
in vivo with the transgenic mouse system [38, 39, 43, 
74, 75]. By using eukaryotic vectors, expression of 
HBsAg has been demonstrated in various cultured 
cells [4, 76 ]. Synthesis of HBsAg in mammalian cells 
has uniformly resulted in production of this gene 
product and its secretion in the form of 22 nm 
particles into the culture medium, which facilitates 
detection and purification [5]. So that knowledge of 
the virus cycle and of its molecular biology is in 
progress. 
The viral surface antigen has a common group 
specific determinant a and carries one member of 
each of the two pairs of mutually exclusive subtype 
determinants d and у [68 ] and w and r [78 ]. Thus 
there are four major subtypes of HBsAg: adw,' adr, 
ayw, and ayr [79]. These subtypes have been recently 
classificated into group A, B, C' and D by Okamoto et 
al. [80]. The groups A, B and D are homogenous 
while group C is not [80]. In this later group the adw 
genome is closely related to the ayr and adr genomes. 
Two by two analysis of the nucleotide sequences show 
some degree of divergence. The divergence is about 
10 % for viruses of different subtypes and about 2 % 
for viruses of the same subtype except for the ayr 
subtype which diverges only 2 % from the adr 
subtype. Occasionally mixed subtypes have been re-
ported in adwr, adyw, adywr and aywr. Both appa-
rently excluded determinants map to the same mole-
cule. It is not known if this represents a double 
infection or an uncommon HBV strain. 
Virion DNA: It has been mentioned above, that 
the HBV genome is a small circular partially double-
stranded DNA molecule. This genome is accompanied 
by a single stranded region of variable length (Fig. 
1). The minus (-) strand is linear and of fixed length 
of about 3200 nucleotides. It is the coding strand from 
which the viral mRNA and the viral pregenomic RNA 
are transcribed. At its 5' end, there is a protein that 
serves as primer for reverse transcription. The plus 
strand (+) is of variable length ranging from 50 to 
100 % that of the minus strand. The maintenance of 
the circular structure is assured by a short cohesive 
overlap region of about 200 nucleotides at the 5' end 
of the two strands. A 12 bp direct repeats (DRI and 
DRII) located near the 5' end of both strands seems 
to serve as a primary site for replication (Fig. 1). 
The first «Т» of the sequence 5'GAATTC in the 
plus strand corresponding to the unique EcoRI site 
which exists in most genomes is used as reference 
origin of physical map. Nucleotides numbering is from 
5' to 3' in the plus strand. When the EcoRI site dose 
not exist the base occupying the same position is 
taken as position 1. 
Physical structure and genetic organization of the 
HBV genome: As a remind and completion, it is 
pointing out that the hepatitis B virus genome con-
tains four overlapping open reading frames genes 
encoding all known proteins of this virus. The enve-
lope open reading frame, or S region (S gene), 
contains three in phase translation start codons 
(ATG) defining the N-termini of three envelope 
polypeptides; pre-Sl, pre-S2 and S protein (The 
hepatitis B surface antigen [HBsAg]) [54, 81, 82]. 
Referring to the ayw subtype [47], the shortest 
polypeptide (226 aa) (aa = amino acid) that contains 
the group a and the subtypes ( d / у , w/r) determinants 
is also called major (small) protein (HBsAg) because 
of in relative abundance. It is encoded by the S region 
starting from the ATG at position 158 (in the adw 
subtype [83 ]). The middle envelope polypeptide con-
tains the entire amino acid sequence of the major 
polypeptide plus 55 aa at the N-terminus containing 
the pre-S2 antigen, starting from the ATG at position 
3214 ([The P31 ATG] in adw subtype [83]). The 
large protein is composed by the entire amino acid 
sequence of the middle envelope polypeptide plus 158 
aa at the N-terminus and bears the pre-Sl antigen 
[52, 82]. The two pre-S antigens are highly immuno-
genic neutralizing epitopes, the larger one being 
involved in the virus binding to cell receptors and in 
the entry in the hepatocytes [82 ]. Many trans-
criptional factors are able to bind to specific sites in 
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the pre-S region of HBV DNA and could be somehow 
responsible for the hepatotropism i. e. HNFl and API 
[83, 84]. 
A glucocorticoid responsive element (GRE) has 
been mapped within the S gene between positions 351 
and 366 (in ayw subtype) [85 ]. This element has no 
enhancer activity but act synergettically with the viral 
enhancer [86 ]. Steroid hormones have been shown to 
positively regulate the S gene expression in transgenic 
mice [87]. (The Enhancer activity will discussed in 
other part of this review.) The capside open reading 
frame or region C (C gene) contains two in frame 
ATG and encodes a nucleic acid binding protein, 
HBcAg, that encapsidate the viral nucleic acids and a 
29 aa longer polypeptide (pre-C) that is secreted as 
HBeAg [88 ]. The X region (X gene) encodes a 
polypeptide expressed during HBV infection and in 
hepatocellular carcinoma [89]. This polypeptide has 
transactivating properties on HBV and other viral and 
cellular promoters [90—92 ]. The P region (P = Pol 
gene) overlaps all the others. It codes for a protein 
with several function in replication; (DNA poly-
merase, RNAse H, primer for DNA synthesis and 
reverse transcriptase [93]). This protein as well as 
reverse transcriptase activity [94, 95], binds to the 
viral DNA 5' terminus of the minus strand [96 ]. 
Three major classes of HBV-specific message are 
detected in infected hepatocytes, and 5' ends of the 
RNAs are heterogeneous (Fig. 2) [41, 54, 97]: the 
3.5-kb RNAs, which are slightly larger than the 3.2 
kb unit length of HBV genome serve as the mRNAs 
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for expression of the core protein. It is also used for 
the synthesis of viral DNA polymerase [7, 8, 98]. 
Because these RNAs are the only species containing 
the full complement of viral genetic information, they 
also serve as templates for reverse transcription 
during HBV replication [8, 97, 99]. Two other 
mRNAs are subgenomic in size: the 2.4 kb RNAs 
encode the large envelope protein HBV surface ,anti-
gen (S-protein), and the 2.1 kb RNAs encode the 
middle and major HEiV surface antigens. Expression 
of these HBV-specific mRNAs is controlled by four 
different promoters in the HBV genome [54]: the 
Core promoter regulates expression of the 3.5 kb 
RNAs, whereas the; pre-S promoter (The distal 
TATA-Iike promoter (SPI)) [4, 100, 101] and the S 
promoter (The proximal Simian virus 40 (SV40)-like 
promoter (SPII)) regulate expression of the 2.4 and 
2.1 RNAs, respectively [44, 102, 103]. Both the SPI 
and the SPII promoters display a preference for 
differentiated hepatoma cell lines [104]. The liver-
and differentiated state-specific transcriptional acti-
vities of the SPI promoter are controlled by the 
combined action of a HNF-I binding element, lying 
between 68 and 95 bp upstream of the; RNA cap site 
in the SPI promoter region [98], and the HBV 
enhancer, which is located downstream of the coding 
sequence of the S gene [104, 105]. 
The liver- and differentiated state-specific trans-
criptional activities of the SPII promoter are contri-
buted mainly by the upstream flanking sequence in 
the promoter region [83, 104, 106]. In addition (0.7 
Fig. 2. Linear representation of the HBV genome. The numbering system of Pasek et al. [481 is used. Transcriptional control regions are 
shown as boxes and are abbreviated as follows: SPJ - pre-SI promoter; SPIJ- pre-S2/S promoter, enh(I)/Xp - enhancer X/I promoter, 
CpIenh(II) - Core promoter/enhancer Π 
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[113]) 0.8 to 0.9 kb mRNA has been detected in the 
in vitro expression system by the DNA transfection of 
HBV DNA [107]. This transcript may be related in 
some way to the expression of the X gene [99], 
controlled by X-promoter. One of the two major 
HBV-specific poly (A+) RN As characterized in infec-
ted livers of chimpanzees is 2.1 kb long [4, 41 ]. This 
transcript codes for the major S protein and appare-
ntly for pre-S2 protein. Thus, four classes of mRNAs 
have been identified so far in the process of HBV 
propagation and are known to use the single poly-
adenylation signal for their termination [99 ]. 
Two similar major transcripts were also observed 
in the infection of other hepadnaviruses, the wood-
chuck hepatitis virus (WHV) and ground squirrel 
hepatitis virus (GSHV). Analysis of Ihe 5' ends of the 
two major transcripts from infected woodchucks and 
ground squirrels indicated that they were hetero-
geneous for all transcripts [108, 109]. For the two 
major transcripts of HBV, however, use of the tran-
sient expression system of transfected HBV DNA 
with HuH-7 cell made possible a similar analysis of 
the heterogeneity of 5' ends of two major transcripts 
[67]. It is mentioned above, thai in human, the 
principal site of clinical pathology after HBV infec-
tions is the liver because HBV actively replicates only 
in hepatocytes [17, 41]. Consistent with this obser-
vation, the 3.5 kb genomic transcript has been detec-
ted primarily in well-differentiated human hepatoma 
cell lines transfected by the cloned HBV genome [67, 
71 ], suggesting that liver-specific factors are needed 
for efficient transcription of the genomic transcripts 
from the core promoter, but although HBV DNA has 
been found in non hepatic tissues in infected patients 
and in transgenic mice [38, 39, 42, 43, 110]. 
Gene Transcripts: All the transcripts already 
described have the same 3' end consisting on a 
polyadenylation site 1916-TATAAA- 1921(111). As a 
result and completion, there are four promoters that 
regulate the expression of the different HBV genes; 
two Surface promoters, one Core promoter, and one 
X promoter. The given positions correspond to that of 
the adw [48 ] HBV genome. 
The pre-Sl promoter: This promoter which con-
tains a TATA box sequence was defined by in vitro 
[101] and in vivo [112] studies; this promoter 
initiates transcription at position 2810 (in adw), 
upstream from the pre-Sl region. Low activity of this 
promoter was found in the human hepatoma Ale-
xander ceil line [31 ] and in the liver of an infected 
chimpanzee [4]. Using stable transformation with 
cloned HBV DNA, it was shown that this TATA 
box-containing promoter is not essential for the 
expression of hepatitis B surface antigen [76]. Thus 
the pre-Sl promoter, which is a canonical TATA 
sequence, located upstream the ATG of the pre-Sl 
region and, produces 2.4 kb transcripts. However, this 
promoter is less functional that the other viral pro-
moters [82]. 
The S promoter; as a second promoter termed 
the S promoter and was characterized and mapped at 
the pre-S2 region. This promoter induces initiation of 
transcription at three major sites, spanning some 
30 bp) around the EcoRI site [4, 5, 76 ]. The position 
of these three initiation sites are 5 nucleotides down-
stream from and 5 and 25 nucleotides upstream from 
the EcoRI site (designated as a, b, and c, respec-
tively). Since the ATG of the pre-S2 region is 
positioned between the b and с initiation sites, only 
the two longest RNA species may code for p31 protein 
with an extra 55 amino acids of the pre-S2 region. 
The shorter species lack the p31 ATG so that the first 
available ATG, at position 158 (in adw subtype), is 
the transcriptional start point of the major S protein. 
It was proposed that the expression of these trans-
cripts in vivo is directed by a sequence positioned 
around the Fnu4HI restriction site (3165 in adw 
subtype) [4] at the region where sequence similarity 
to the SV40 late promoter was been shown. Thus the 
S promoter is located round position 3155 (in ayw 
subtype) just upstream to the translation site of the 
middle protein and produces 2.1 kb transcripts [4' 
The 5' ends of these transcripts are heterogeneous 
and encodes both the major (small) and middle 
protein. Despite the extensive mapping of S gsne 
mRNA initiation sites, little is known about regu-
latory elements which modulate the S promoter. 
Transient expression studies revealed that ibis 
promoter is highly active in the Alexander 
(PLC/PRF/5) hepatoma cell line but not in SK-Hepl 
and HeLa cells. It has been determined that a distal 
element of the promoter (-103 to -48) confers this 
cell-type-specific behavior through a mechanism in 
which the promoter activity repressed in HeLa and 
SK-Hepl cell but increased in Alexander cells [83]. 
It has been also found an enhancer like activity 
associated with a small DNA segment of the S 
promoter (-27 to +30) [83]. This proximal element 
actives in HeLa and SK-Hepl cells only in the 
absence of the distal negative element. Finally, ana-
lysis of S promoter deletion mutants demonstrated 
that the -27 to -17 region of the S promoter is crucial 
for its activity [83 ]. 
The X promoter; has not been precisely located 
[107]. It is weakly active in vivo and represent less 
than 1 % of the viral transcripts. In in vitro system, 
0.7 kb and 0.9 kb transcripts have been reported 
[113]. This promoter seem to be more efficient out of 
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the whole HBV genome context. Since the HBV X 
protein (pX) trans-activates many promoters [114], 
including the HBV Core promoter [91 ], it is deter-
mined that pX not regulates the pre-Sl or S promoter 
(pX has not trans-effect on the Surface gene pro-
moters). 
The Core promoter; regulates the replication of 
the virus, as the 3.5 kb C mRNA/pregenome not only 
serves for translation of the Core and Pol proteins but 
also represents the template for reverse transcription 
[97, 115, 116]. From the second Core promoter 
transcript, the pre-C mRNA, only the HBeAg precur-
sor is translated [115, 116]. The Core promoter is 
composed of a minimal or basic Core promoter <BCP) 
sufficient to initiate transcription and of upstream 
regulatory sequences (URS) [117—119]. A short 
TA-rich sequence in the BCP serves as both the 
initiator and TATA box for transcription initiation of 
the pre-C mRNA and C mRNA/pregenome, respec-
tively [120]. 
An important activating URS element is the alpha 
box (see part of Regulatory Elements of HBV genome 
in this review), which binds hepatocyte nuclear factor 
4 (HNF4), C/EBP, or other liver-specific trans-
cription factors [110, 117, 118, 121—124]. In addi-
tion, binding sites for HNF3 and ubiquitous factors 
like SPI were identified in this promoter [125, 126]. 
Unlike the pre-Sl promoter, the Core promoter of 
wild-type HBV does not contain an HNFl binding 
site [127]. 
Because of its crucial role in the viral life cycle, 
naturally occurring sequence variation in the Core 
promoter of HBV in patients is under intense inves-
tigation. Specific point mutations in the BCP were 
found in HBV from patients with fulminant hepatitis 
[128—131]. Similar mutation as well as different 
short deletions or insertions were found in viremic 
HBeAg-negative patients with chronic hepatitis B 
[129—134]. 
Since for these patients no mutation in the C 
gene could explain the lack of HBeAg expression, it 
was speculated that promoter mutation may be res-
ponsible. Specific types of short deletions in the Core 
promoter region were found in patients with extre-
mely low-level viremia, in some cases without any 
serological marker for HBV infection [135—138]. 
Thus, a particular phenotype may be caused by 
specific mutations in the Core promoter. However, 
this speculation has not previously been substantiated 
by experimental evidence [93]. At last the Core 
promoter, produces transcripts of 3.5 kb. Three 5' 
ends have been located upstream of the C gene: two 
of them initiating downstream of the ATG of pre-C 
region, coding for the major capsid antigen (HBcAg) 
and the genomic viral DNA, and another one starting 
ups tream region pre-C coding for the HBeAg [67 |. A 
C gene specific 2.1 kb spliced transcript that represent 
the 2.1 kb S transcripts has been described [1391. 
A polymerase gene promoter has not been iden-
tified. The 3.5 kb transcripts that have heterogeneous 
5' ends [108] could also encode the polymerase gene 
products. 
Regulatory Elements of HBV genome: Eukarvotic 
gene expression is in large part regulated at the 
transcription, level. Such regulation is governed by the 
constellation of trans-acting cellular factors that bind 
to specific as-acting elements and act in either a 
positive or negative manner [140]. Cell-type-specific 
gene activation a primary' determinant of cellular 
differentiation, represents a more complex type of 
interplay, as both constitutive arid tissue-restricted 
trans-acting regulatory factors are involved [1,41]. 
The differential sequence-specific recognition of these 
cis-acting elements in promoters and/or enhancer s by 
their cognate factors provides a mechanistic basis for 
the tissue- and differentiation-specific regulation of 
gene expression. The study of model viral genes 
which display distinct tissue tropism can provide 
valuable insight into the intricate effects of cell-type-
specific transcription regulation on differentiation. It 
has been mentioned above, that control of gene 
transcription in part regulated by the presence of 
cis-acting DNA elements that interact with specific 
nuclear transcription factors. Enhancers, which act in 
a position- and orientation-independent mannner, are 
key regulatory elements in the transcriptional regu-
lation of viral and cellular genes [142, 143 ]. The 
72-bp repeat of simian virus 40 (SV40) is the best-
characterized enhancer. 
The SV40 72-bp enhancer, which is composed of 
multiple regulatory cis-acting elements via the inter-
action whit ubiquitous and cell-type-specific trans-
criptional factors, orchestrates the expression of viral 
genes in many cells [144—146]. Two regions of the 
HBV genome are known to display properties of a 
transcriptional enhancer (Fig. 2) [147—149]. A 
transcriptional region, Enhancer I, is located between 
the open reading frames of the surface antigen, within 
the region P, and upstream the X region (position 
1074—1234 in ayw subtype) and partially overlaps the 
X promoter [147, 150]. Because activation of trans-
cription by this enhancer is greater in several cultured 
hepatoma cells than in nonhepatic cells, it has lieen 
suggested that this enhancer is responsible for liver-
specific gene expression of HBV [150]. It is described 
the identification of a second enhancer sequence 
(enhancer II) in the HBV genome: Enhancer II is 
situated downstream of the previously identified en-
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hancer (enhancer I), immediately upstream from the 
coding region of the Core gene (initiation site of viral 
major transcript) [152], overlaps with the Core pro-
moter [93], within the X open reading frame [98, 
152]. 
Enhancer II has been mapped to nt 1636 to 1741 
[123] in HBV genome. It furnishes a unique model of 
use in investigating the structure and function of an 
enhancer. Unlike enhancer I, the activity of enhancer 
II is highly liver specific, functioning only in highly 
differentiated human hepatoma cells. Furthermore, 
enhancer II activity varies in different hepatoma lines, 
suggesting that this enhancer is regulated according 
to the differentiation state of the hepatoma line used. 
Because enhancers have been shown to play a pivotal 
role in the regulation of mammalian and viral gene 
expression and because HBV gene expression is 
tightly coupled to the step of reveres transcription in 
this replication cycle, a mechanism for regulation of 
HBV enhancer activity may clarify the molecular 
basis for the absence of HBV replication and gene 
expression in hepatocellular carcinoma [22]. With 
various deletions at the 5' end of enhancer II, a 
positive regulatory element was identified at nt 1636 
to 1690 (the II-A element), with the 5' boundary 
between nt 1636 and 1671. The II-A Element alone 
did not have an enhancer function, but the enhancer 
activity was been achieved by the concomitant pre-
sence of the sequence from nt 1704 to 1741 (the II-B 
element). The II-B Element alone did not have 
enhancer activity. These facts indicate that coope-
ration between the II-A and II-B elements is required 
to exhibit the enhancer activity of enhancer II [98 ]. 
Two functional constituents, a 23-bp sequence box-α 
in the II-A element and a 12-bp sequence box-β in 
II-B element, were identified as being both necessary 
and sufficient for enhancer II function [123]. Interes-
tingly, either box-a or box-/? in an upstream position 
can regulate the activity of the nearly Core promoter 
[119]. 
Examination of the box-α and box-β sequences 
reveals a weak homology to the extended consensus 
for a C/EBP binding site. Gel shift and footprinting 
analyses indicate that multiple proteins bind to these 
sequences and thus are candidate transcription factors 
that mediate the enhancer function. One heat-resis-
tant protein, protein a, and one heat-sensitive pro-
tein, protein b, bind to box-α. Protein a, which bind 
to box-α in a way indistinguishable from that seen 
with a recombinant C/EBP, appears not to be iden-
tical to C/EBP in that the binding of protein a 
requires a minimal sequence larger than the canonical 
C/EBP sites. 
Two box-/?-binding proteins с and d, show gre-
ater affinity for the C/EBP consensus than for 
Ъох-β. However, both proteins с and d are relatively 
heat sensitive and display a distinct sequence prefe-
rence from the recombinant C/EBP protein. Since the 
function of enhancer II is strictly dependent on a 
bipartite architecture, this system provides a unique 
model for studies of how the interactions of its 
binding proteins lead to the enhancer function. Fur-
thermore, proteins that display binding activities to 
box-α and box-/? are found to be present in nuclear 
extracts of the differentiated human hepatoma cell 
line HepG2 by DNAse I footprinting and gel shift 
analyses [123]. Using DNA transfection to bypass 
viral entry into cells, it has been demonstrated that 
the expression of HBV genes exhibits liver cell and 
differentiation state specificity in the infective process 
in vivo [64, 66, 67, 71, 104, 153—155]. Previous 
studies show that only in the human hepatoma cell 
lines HepG2 and HuH-7, which have the feature of 
well-differentiated liver cells, does enhancer II have 
strong enhancing activity on the simian virus 40 
(SV40) early promoter [1101. In contrast, this is not 
seen in the poorly differentiated HA22T/VGH cells 
or the nonliver HeLa cells [98 ]. These results also 
apply to the upstream regulatory effect on the bast. 
Core promoter (BCP) [119]. These differentiateo 
actions, therefore, may contribute at least in part to 
the observed hepatotropism of HBV. It has been 
mentioned above that gel shift experiments reveal a 
unique box-a-binding protein, protein a, which is 
present only in differentiated liver cells, where en-
hancer II is functional. The converse is true for 
another box-a-binding protein, protein /, which is 
present only in poorly differentiated liver cells and 
nonliver cells. The simplest hypothesis that explains 
these results is that protein a activates and/or protein 
/ suppresses the enhancer and upstream regulator 
functions. 
Although C/EBP is a candidate for a trans-
cription factor that interacts with box-α or box-β, 
none of the binding factors identified in the gel shift 
assays, including protein a and protein /, is likely to 
be C/EBP because they differ from C/EBP in heat 
liability and sequence preference [117]. In addition, 
enhancer II consists an upstream negative regulatory 
element [98, 110, 122, 124, 152, 156]. Enhancer II 
activates the transcriptional activity of both the SPl 
and SPII promoters in a liver- and differentiated 
state-specific manner [98 ]. 
It has been shown that the two HBV enhancers 
strongly effect the activity of all three major HBV 
promoters in human hepatoma cells and that the 
activity of HBV enhancers is differentially regulated, 
depending on the state of hepatocyte differentiation. 
116 
THE HEPATITIS B VIRUS: GENERAL DESCRIPTION 
Ф. Аджаміян 
Вірус гепатиту В: загальний опис, фізична структура, генетична 
організація, транскрипція генів та геномні регулюючі елементи 
Резюме 
Геном вірусу гепатиту В людини (HBV) існує у вигляді 
дволанцюгових кільцевих молекул ДНК. Він містить чотири 
фланкуючі відкриті рамки зчитування (ORFs) генів. S (preSl, 
preS2) регіон(и) кодує головний, середній та великий білки 
(HBsAg). C і ргеС регіони кодують HBcAg і HBeAg. X регіон 
кодує поліпептид, який експресується за час HBV інфекції. P 
регіон кодує білок з різноманітними функціями у реплікації. 
Ідентифіковано чотири класи HBV мРНК. У геномі HBV 
pre-Sl промотор продукує великий білок, pre-S2/S виробляє 
головний і середній білки. X промотор кодує 0,7 і 0,9 траі с-
крипти. C і пре-С промотори кодують Core і pol(HBVcAg) і 
HBeAg білки. Ключовими регуляторними елементами HBV є 
енхансери І і II. Активність енхансера II є специфічною для 
печінки. Він активує транскрипцію обох npe-Sl і npe-S2/S 
промоторів. Два HBV енхансери активують основні промото-
ри HBV. SoKC-a в II-A і бокс-β в II-B елементах у геномі HBV 
необхідні для функції енхансера II. Бокси а і β можуть 
регулювати активацію промотора Core, білки a, b, f і білки с, 
d прикріплюються у боксах а і β відповідно і впливають на 
енхансерну функцію. 
Ф. Аджамиян 
Вирус гепатита В: общее описание, физическая структура, 
генетическая организация, транскрипция генов и геномные 
регулирующие элементы 
Резюме 
Геном вируса гепатита В человека (HBV) существует в виде 
двухцепочных кольцевых молекуул ДНК. Он содержит четыре 
фланкирующие открытые рамки считывания (ORFs) генов. S 
(npeSl, npeS2) регион/ы) кодирует главный, средний и боль-
шой белки (HBsAg). С и пре-С регионы кодируют HBcAg и 
HBeAg. X регион кодирует полипептид, репрессирующийся в 
течение HBV инфекции. P регион кодирует белок с разнообраз-
ными функциями в репликации. Идентифицированы четыре 
класса HBV мРНК. В геноме HBV npe-Sl промотор продуци-
рует большой белок, npe-S2/S промотор производит оба 
(главный и средний) белка. X промотор кодирует 0,7 и 0,9 
транскрипты. С и пре-С промоторы кодируют Core и 
Pol(HBcAg) и HBeAg белки. Ключевыми регуляторными эле-
ментами в HBV являются энхансеры I и II. Активность 
энхансера II очень специфична для печени. Энхансер II активи-
рует транскрипционную активность npe-Sl и npe-S2/S про-
моторов. Два HBV энхансера активируют основные промото-
ры HBV. Бокс-α в II -A и бокс-β в Il-B элементах в геноме HBV 
необходимы для функции энхансера II. Боксы а и β могут 
регулировать активацию Core промотора, белки a, b, f и белки 
с, d прикрепляются в боксах а и β соответственно и дейст-
вуют на энхансерную функцию. 
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